Fertility testing is a group of medical procedures that measure reproductive health by examining hormone levels, structural anatomy, egg production, and sperm function. These tests help identify whether infertility has a physical cause and guide decisions about treatment.
Most fertility tests are straightforward office procedures—blood draws, ultrasounds, semen analysis, or imaging—and together they take weeks to months to complete. Testing is typically recommended after one year of unprotected intercourse without pregnancy (or six months if the woman is over 35), when there are known reproductive health concerns, or before pursuing assisted reproduction. A patient should understand what each test measures, what the results do and do not tell them, and that many results are normal even when pregnancy has not occurred.
Table of Contents
- When Fertility Testing Makes Sense
- Tests That Measure Hormone Levels
- Ultrasound and Structural Imaging
- Sperm Analysis and Partner Testing
- Other Diagnostic Procedures
- Interpreting Results and Normal Variation
- Testing Timeline and Cost
- What Results Do Not Tell You
- Next Steps After Testing
- Choosing to Test or Decline Testing
- Frequently Asked Questions
When Fertility Testing Makes Sense
Testing is most useful after trying to conceive without success for a defined period. The standard guideline is one year of unprotected intercourse for couples where the woman is under 35. Women over 35 are typically evaluated after six months because egg quality declines with age, and women over 40 often move straight to testing if pregnancy does not occur immediately.
These timelines exist because many couples conceive without intervention during this window, so testing everyone earlier would identify normal variation as problems. Testing may happen sooner when known risk factors are present. These include irregular or absent periods, a history of pelvic infection or endometriosis, previous pelvic surgery, a diagnosis of polycystic ovary syndrome (PCOS), abnormal cervical exams, a partner with known low sperm count, or age over 40.
Some patients choose testing before attempting pregnancy—for example, to confirm ovulation is happening, to assess egg reserve, or because a medical condition (like cancer treatment) might affect fertility. Conversely, testing is not automatically needed after a few months of trying or after one missed cycle. Timing of ovulation varies, and a single cycle without pregnancy is not evidence of infertility.
The decision to test is a conversation between the patient and their clinician, informed by age, medical history, and personal circumstances. Knowing when testing actually addresses a question—rather than generating anxiety about normal variation—helps patients decide whether to pursue it. Testing may also be part of planning for assisted reproduction, even without a history of infertility.
Some patients using sperm donation, egg freezing, or in-vitro fertilization need testing to establish baseline function or to screen for conditions that might affect treatment choice. In these cases, testing guides planning rather than answering a question about why conception has not occurred. Testing does not diagnose age-related fertility decline itself. Age is a known factor in fertility, and testing cannot reverse it; the tests measure egg count and hormone patterns, which correlate with age but do not definitively predict pregnancy for any individual. A patient should understand that testing provides information about the present state, not predictions about future outcomes.
Tests That Measure Hormone Levels
Hormone tests use blood draws to assess the body's reproductive signaling. The most common are follicle-stimulating hormone (FSH), luteinizing hormone (LH), and estradiol, which regulate ovulation, and testosterone and prolactin, which can affect fertility when abnormal. These are typically drawn on day 3 of the menstrual cycle (counting day 1 as the first day of bleeding), when baseline hormone levels are most stable and interpretable.
FSH is the hormone that stimulates egg production. A high FSH level (typically over 10 mIU/mL) can suggest the ovaries are not responding strongly to the signal, which may correlate with lower egg reserve. However, a single FSH result is not diagnostic—some patients with high FSH conceive naturally, and some with normal FSH struggle to become pregnant.
FSH is most useful as one piece of information, not as a standalone answer. LH works with FSH to trigger ovulation. In patients with PCOS, LH is often elevated relative to FSH, which is one pattern doctors look for. Estradiol levels help assess egg development and ovarian reserve; very high baseline estradiol can falsely lower FSH and obscure the picture.
Thyroid hormone (TSH) is almost always tested because thyroid disorders affect fertility and pregnancy. Even mildly elevated or low TSH can interfere with ovulation, and untreated thyroid disease increases miscarriage risk. Many fertility clinics treat TSH as a required baseline. Prolactin, a hormone that causes milk production, is checked if periods are absent or irregular.
Elevated prolactin suppresses ovulation and can prevent pregnancy even if ovulation is occurring intermittently. This is one of the most common hormonal causes of absent or irregular periods and is easily treated with medication. Anti-Müllerian hormone (AMH) is a newer test that measures the number of eggs remaining in the ovaries—often called "egg reserve." AMH is not tied to a specific day of the cycle and can be drawn any time.
Low AMH suggests lower egg count, while high AMH suggests more eggs available. Like FSH, AMH is useful context but does not predict fertility alone. Young patients with low AMH may still conceive without assisted reproduction; older patients with normal AMH may struggle to conceive. A complete hormone workup typically costs $200–$600 depending on which tests are ordered and the clinic's fees. Insurance may cover some or all of this if it is ordered as part of infertility evaluation, but coverage varies by plan.
Ultrasound and Structural Imaging
Pelvic ultrasound is usually performed transvaginally (a small probe inserted into the vagina) and takes 10–20 minutes. It visualizes the uterus, fallopian tubes, and ovaries and is often the first imaging test ordered. Ultrasound can reveal large fibroids (benign growths in the uterus), polyps, ovarian cysts, or structural abnormalities that might interfere with pregnancy or require treatment.
The ovaries are examined to count the number of small follicles (antral follicle count, or AFC), which correlates with egg reserve. Counting follicles in both ovaries is a real-time assessment and is straightforward to perform. Results are reported as a number (for example, "10 follicles on the left, 8 on the right"). Higher counts suggest more eggs available; lower counts suggest fewer, though the number alone does not determine fertility.
Ultrasound can detect polycystic ovaries, which appear as many small cysts arranged in a "string of pearls" pattern around the edge of the ovary. The presence of polycystic ovaries on ultrasound, combined with elevated LH or other hormone changes, supports a PCOS diagnosis. Hysterosalpingography (HSG) is an X-ray procedure in which dye is injected through the cervix into the uterus and fallopian tubes.
If the tubes are open, the dye flows through them into the abdominal cavity. An open tube is visualized on the X-ray; blocked tubes show dye stopping or backing up. HSG takes about five minutes and is performed in a radiology suite. Some patients experience cramping or moderate pain during the procedure, and spotting for a day or two afterward is common.
Sonohysterography (SHY) uses ultrasound instead of X-ray and is performed in a clinic setting. Saline is injected into the uterus while ultrasound visualizes the cavity and tubes. Some clinicians prefer this over HSG because it avoids radiation and allows real-time visualization, though it requires more expertise to perform well. Both HSG and SHY are performed after the period ends and before ovulation (roughly days 7–12 of the cycle), when the endometrium is thin and visualization is clearest.
These tests are scheduled only once per cycle, so timing matters for getting an appointment. Neither test prevents pregnancy; in fact, the dye used in HSG may have a mild fertility benefit for a few months after the procedure.
Sperm Analysis and Partner Testing
A semen analysis (also called a sperm test) measures sperm count, movement, shape, and overall function. The patient produces a sample by masturbation in a private room at a fertility clinic or lab, and the sample is analyzed under a microscope. Results are available within one to two weeks. The test measures sperm concentration (number of sperm per milliliter—normal is over 15 million per mL), motility (percentage of sperm that are moving, and how fast—normal is over 40% with forward movement), and morphology (percentage of sperm with normal shape—normal is over 4%).
These numbers come from WHO (World Health Organization) standards that are updated periodically as reference ranges change. Low sperm count (oligospermia), poor movement (asthenospermia), or abnormal shape (teratospermia) can reduce fertility, though normal semen analysis does not guarantee pregnancy will occur. Some men with low sperm count conceive naturally; some with normal results have difficulty with conception.
The test is affected by recent illness, fever, stress, smoking, and caffeine use in the weeks before the sample is produced. If results are abnormal, a second test is usually ordered a few weeks later to confirm, because a single sample may not represent typical production. A follow-up test called a semen culture may be done if sperm count is low or there are symptoms of infection.
Anti-sperm antibodies—the patient's own immune system attacking sperm—can be tested if there are other indicators, though this test is less commonly ordered now. Advanced sperm tests like DNA fragmentation analysis measure whether sperm DNA is damaged, which can affect embryo development. These are more specialized tests used by fertility specialists when standard results do not explain difficulty conceiving.
They typically cost more and may not be covered by insurance. A basic semen analysis costs $150–$300 depending on the lab. Some insurance plans cover one analysis as part of infertility evaluation.
Other Diagnostic Procedures
Hysteroscopy is a procedure in which a thin camera is inserted through the cervix into the uterus under anesthesia, allowing direct visualization of the uterine cavity. It is used to confirm or biopsy endometrial polyps, remove fibroids, or diagnose Asherman's syndrome (scar tissue inside the uterus). It is more invasive than ultrasound or HSG and is usually reserved for patients with abnormal ultrasound findings or when HSG suggests a possible blockage that needs clarification.
Laparoscopy is a surgical procedure in which a tiny camera is inserted through a small incision near the navel, allowing the surgeon to visualize the uterus, tubes, and ovaries directly. This procedure can diagnose endometriosis, which cannot be definitively diagnosed any other way, and can also reveal adhesions (scar tissue) or tube damage. Laparoscopy requires general anesthesia and carries surgical risks, so it is reserved for specific situations—for example, a patient with severe pelvic pain or when HSG suggests a tube problem that needs clarification.
Genetic testing is sometimes recommended before attempting pregnancy or assisted reproduction. A carrier screen tests whether the patient carries genes for certain inherited conditions, which can inform reproductive choices. This is typically a blood test and is increasingly offered as part of routine preconception counseling, particularly for patients with a family history of genetic disease.
Infectious disease screening—tests for sexually transmitted infections and other pathogens that might affect pregnancy—is standard before attempting pregnancy or starting fertility treatment. These are blood tests and are straightforward to perform.
Interpreting Results and Normal Variation
Fertility test results exist on a spectrum, and "normal" does not guarantee pregnancy will occur, just as an abnormal result does not guarantee it will not. The reference ranges used (for example, FSH under 10, sperm count over 15 million per mL) are statistical—they represent the range where most fertile people fall—but a patient slightly outside the range may still conceive naturally, and one solidly within the range may struggle.
Some abnormal results are clearly actionable. A very high prolactin level (say, 200 ng/mL) is almost always the cause of absent periods and is reliably treated with medication. Low sperm count below 5 million per mL is associated with reduced fertility. High FSH over 15 suggests lower egg reserve and may affect prognosis, particularly combined with age.
Other abnormalities are subtle and require clinical judgment. A follicle count of 6–8 might be considered low reserve by some standards but normal by others. Many fertility specialists now avoid labeling counts as definitively "low" and instead discuss what the count means in context of age and other factors. This nuance is often lost in the patient's initial conversation with the clinician, leading to unnecessary worry.
A blocked fallopian tube identified on HSG is clearly abnormal and typically requires further evaluation or treatment. However, the same blocked tube does not prevent pregnancy if the other tube is open; pregnancy can still occur with one tube. If both tubes are blocked, pregnancy is unlikely without in-vitro fertilization (IVF). Mild abnormalities in semen parameters do not always require intervention.
A sperm count of 10 million per mL or motility of 35% is below the WHO cutoff but may still allow natural pregnancy, particularly if the patient's partner is under 35 and other results are normal. The decision to treat is individualized based on duration of infertility, the patient's age, and the clinician's assessment. Ultrasound findings like a small fibroid, a single cyst, or mild ovarian polycysts are common and often benign.
The presence of these findings does not always require treatment or mean pregnancy is impossible. The clinician should explain which findings matter and which are incidental.
Testing Timeline and Cost
A typical fertility workup spans four to eight weeks. Hormone tests are drawn early in the cycle; ultrasound is performed mid-cycle; HSG is scheduled in the follicular phase. If abnormal results warrant further testing—a repeat semen analysis, an ultrasound follow-up, or imaging like hysteroscopy—the timeline extends. The out-of-pocket cost for a full testing panel (hormones, ultrasound, HSG, semen analysis, basic screening) typically ranges from $1,200 to $3,000, depending on what is ordered and whether insurance covers any portion.
Individual tests are less expensive (a single ultrasound may be $200–$500), but comprehensive testing is more costly. Insurance coverage varies widely. Some insurance plans cover all standard fertility testing as part of infertility evaluation; others cover minimal testing; some cover nothing related to infertility. A patient should contact their insurance company before testing to understand what is covered and what out-of-pocket costs to expect.
Many fertility clinics have financial counselors who help navigate insurance and offer payment plans for uninsured patients. Some testing costs less at routine obstetrics or primary-care clinics than at specialized fertility centers. Hormone tests and basic ultrasound can be ordered by any physician. Specialized testing like HSG or semen analysis may be available at general imaging centers or urology offices.
Shopping for pricing on routine tests can reduce overall cost, though tests ordered through a fertility specialist may be more targeted and cost-effective overall. Fertility testing is not an emergency, so a patient can take time to understand costs, verify insurance coverage, and choose where to have tests performed. This contrasts with diagnostic testing for a medical emergency, where time pressure is immediate.
What Results Do Not Tell You
Fertility testing provides a snapshot of reproductive health at one point in time. It does not predict whether a specific person will become pregnant, and it cannot explain all cases of infertility. Roughly 10–15% of couples with infertility have normal testing across all standard measures; in these cases, infertility is labeled "unexplained," and the cause remains unknown.
Testing does not measure "fertility potential" or "biological clock" with precision. Age is the strongest predictor of natural conception and successful assisted reproduction, but two people of the same age with identical test results may have very different outcomes. Individual variation is large. Test results do not measure sperm function in the context of an actual egg (fertilizing ability in vivo) or egg quality in detail—only egg number and hormone patterns.
Some couples with normal testing struggle to achieve fertilization in an IVF setting, suggesting a subtle interaction between egg and sperm that standard tests do not measure. Results do not measure the uterine lining's receptivity to implantation or whether a normal-appearing embryo will progress to pregnancy. These are complex biological events that testing cannot fully evaluate.
Emotional or psychological factors affecting fertility are not measured by any of these tests. Stress, anxiety, or depression do not "cause" infertility in a physiologic sense, but they can affect sexual function, timing, and overall well-being during the conception process. A normal test result does not mean pregnancy will occur soon, and an abnormal result does not mean pregnancy is impossible.
Test results inform treatment decisions and set expectations, but they are not destiny. Clinicians should help patients understand what their results mean for their specific situation, not apply results mechanically.
Next Steps After Testing
If testing reveals a clear abnormality—such as a high prolactin level, a blocked tube, or very low sperm count—the next step is usually treatment specific to that finding. High prolactin is treated with dopamine agonist medication. A blocked tube may be evaluated with hysteroscopy or referral for surgical evaluation. Low sperm count may be evaluated further by a urologist or fertility specialist.
If testing is entirely normal and pregnancy has not occurred, the options are to continue attempting natural conception, to move forward with assisted reproduction (intrauterine insemination or IVF), or to reassess over time. This decision depends on age, how long conception has been attempted, and the couple's preferences. A fertility specialist can help weigh these options.
If testing shows mild abnormalities (for example, a slightly elevated FSH or a follicle count at the lower end of normal), the decision is more nuanced. Some clinicians recommend treatment; others recommend continued observation. The patient's age and duration of infertility inform this discussion. For a 32-year-old with mild findings, waiting a few more months is reasonable.
For a 40-year-old with mild findings, moving to assisted reproduction may be more time-sensitive. If testing is inconclusive—results are borderline, or some tests are abnormal while others are normal—a second opinion from another fertility specialist can help clarify interpretation and guide next steps. If a patient declines further treatment after normal or mildly abnormal testing, counseling about the decision—whether based on cost, emotional burden, or other reasons—is important. A clinician should ensure the patient understands the implications and feels supported in their choice.
Choosing to Test or Decline Testing
Testing is optional, and a patient can decline it and continue attempting natural conception indefinitely. Some patients choose not to test because of cost, because they want to avoid the emotional weight of labeled results, or because they prefer to let conception happen on its own timeline without medical involvement. Other patients choose to test because they want information to guide decisions, because their age makes delaying risky, or because known risk factors make answers feel important.
Both choices are valid and depend on individual circumstance and preference. A patient should understand that testing is most useful when it will change management—for example, when the patient's age means time is a factor, or when known medical history suggests a likely cause. Testing for the sake of having results, without a clear plan for what to do with them, can create more anxiety than clarity.
Before testing, a patient should have a clear conversation with their clinician about what tests are proposed, why, what results might mean, and what the next steps would be depending on findings. A patient should also understand costs, insurance coverage, and the timeline before committing. Once testing is complete, the results should be discussed thoroughly.
If a result is abnormal, the clinician should explain what the abnormality means, whether it is thought to affect fertility, and what treatment (if any) is recommended. If results are normal, the clinician should affirm that the patient's results do not explain infertility and discuss the options for moving forward.
Frequently Asked Questions
How long does a complete fertility workup take?
A full testing panel typically spans four to eight weeks, depending on timing of blood draws, when imaging is scheduled, and whether additional tests are needed based on initial results. Some tests are ordered on specific cycle days, so scheduling matters.
Does normal fertility testing mean I'll get pregnant naturally?
Normal testing means no obvious physical barrier to pregnancy was found, but it does not guarantee pregnancy will occur. About 10–15% of couples with infertility have entirely normal testing, and some couples with abnormal results conceive naturally. Testing provides information, not predictions.
What is the most important test when trying to conceive?
The most important test depends on the situation. For someone who has not menstruated in months, a prolactin test may be critical. For a couple after a year of trying, a combination of hormone testing and ultrasound is typical. For a male partner, semen analysis is key. A clinician helps prioritize based on age and medical history.
If my FSH is high, does that mean I can't get pregnant?
High FSH suggests lower egg reserve, but it does not mean pregnancy is impossible. Many people with elevated FSH conceive naturally. High FSH is most useful as context combined with age and other factors. A single number does not determine fertility.
Why is semen analysis done only once?
A single semen sample may not represent typical production if the patient was ill, stressed, or had recent ejaculation. If results are abnormal, a second test weeks later is usually ordered to confirm. Normal results do not need retesting unless circumstances change.
Can I get pregnant if my fallopian tube is blocked on one side?
Yes. If one tube is open, pregnancy can still occur because an egg can travel down the open tube. If both tubes are blocked, pregnancy is unlikely without in-vitro fertilization. A blocked tube does not affect the other side's function.
